Jordan vs Slovakia: The number of people with susceptibility test result for rifampicin
Jordan
62
in 2021
Slovakia
65
in 2021
Jordan rank
117th
Slovakia rank
116th
The number of people with susceptibility test result for rifampicin over time
- Jordan
- Slovakia
How they compare
Slovakia currently reports 65 against 62 in Jordan, a difference of 3.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Slovakia ahead.
Jordan ranks 117th and Slovakia ranks 116th of 155 countries.
Across the 2 decades both report, Jordan averaged higher in 1 and Slovakia in 1.
Head to head by decade
| Decade | Jordan | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 84.33 | 97.67 | 13.33 | Slovakia |
| 2020s | 86 | 58 | 28 | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Jordan or Slovakia?
- Slovakia, at 65 against 62 in Jordan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Jordan and Slovakia?
- 3, with Slovakia ahead.
- How many years of comparable data are there for Jordan and Slovakia?
- 5 years are reported by both, from 2017 to 2021.
- How do Jordan and Slovakia rank globally for the number of people with susceptibility test result for rifampicin?
- Jordan ranks 117th and Slovakia ranks 116th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.